SOPH | SOPHiA GENETICS SA Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.23 - 3.32
52 Week Range	2.7000 - 6.28
Beta	1.09
Implied Volatility	203.32%
IV Rank	42.33%
Day's Volume	6,552
Average Volume	80,210
Shares Outstanding	66,831,100
Market Cap	219,206,008
Sector	Healthcare
Industry	Medical - Healthcare Information Services
IPO Date	2021-07-23

Valuation
Profitability
Growth
Health
P/E Ratio	-3.45
Forward P/E Ratio	N/A
EPS	-0.95
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	430
Country	Switzerland
Website	SOPH

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

SOPH's peers: HSTM, NRC, NXGN, FORA, AGTI, MDRX, CPSI, DH, PRVA, EVH, SLP, SHCRW, CMAX, AUGX, PINC

*Chart delayed

Analyzing fundamentals for SOPH we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see SOPH Fundamentals page.

Watching at SOPH technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SOPH Technicals page.